April 29, 2022
The Oncology Institute of Hope and Innovation (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, recently acquired Women’s Cancer Care, the practice of Christopher R. Perkins, M.D. and Lisa Ge, M.D. Established in 2001, Women’s Cancer Care is the only clinic between San Francisco and Los Angeles specializing in breast and gynecology oncology patients and will expand TOI’s footprint north into Fresno, California.
“I am thrilled to join the exceptional care providers at TOI, which will elevate the outstanding medical and cancer resources available to women across the Central Valley,” said Dr. Perkins. “Our patients will benefit greatly from the cutting-edge care solutions that TOI provides, and I look forward to growing this practice to serve even more patients.”
The Fresno facility will provide patients with the same advanced medical services and resources available to patients at all TOI locations and adds a staff of more than 30 to expand TOI’s growing footprint of clinicians and employees changing oncology for the better. Drs. Perkins and Ge are the leading breast cancer specialists in the Central Valley and have extensive experience with the development of new clinical operations.
“The addition of Women’s Cancer Care offers a unique opportunity for TOI to not only expand our footprint into the Central Valley, but also provide care to a focused patient population that will benefit from our leading clinical research programs, care management resources, and more,” said Daniel Virnich, M.D., President at TOI. “We are excited to bring Women’s Cancer Care into TOI’s practice to build on the exceptional care services Dr. Perkins and his team of providers and clinicians have delivered for more than 30 years.”
About The Oncology Institute
Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.6 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 80+ employed clinicians and more than 600 teammates in 50 clinic locations and growing, TOI is changing oncology for the better.
Never Miss a Report